Trial intelligence / Profile preview

Apomorphine Pump for Sleep Quality in Parkinson's Disease

NCT02688465Phase 4Terminated

Sponsor
Adolphe de Rothschild Foundation Hospital
Start
Sep 2016
Primary completion
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of apomorphine in Parkinson's disease (PD), sponsored by Adolphe de Rothschild Foundation Hospital. Started Sep 2016; status: terminated.

02

Drugs

apomorphine
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT02688465.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02688465.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call